Oral contraceptive use increases risk of inflammatory and coagulatory disorders in women with Polycystic Ovarian Syndrome: An observational study. [electronic resource]
Producer: 20201023Description: 10182 p. digitalISSN:- 2045-2322
- Adult
- Body Mass Index
- Coagulation Protein Disorders -- etiology
- Contraceptives, Oral -- adverse effects
- Ethinyl Estradiol -- therapeutic use
- Female
- Humans
- India
- Inflammation -- etiology
- Insulin -- therapeutic use
- Insulin Resistance
- Levonorgestrel -- therapeutic use
- Metformin -- administration & dosage
- Polycystic Ovary Syndrome -- blood
- Risk Factors
- Waist-Hip Ratio
- Young Adult
No physical items for this record
Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.